genOway Société anonyme Balance Sheet Health
Financial Health criteria checks 5/6
genOway Société anonyme has a total shareholder equity of €17.1M and total debt of €8.1M, which brings its debt-to-equity ratio to 47.5%. Its total assets and total liabilities are €32.6M and €15.5M respectively. genOway Société anonyme's EBIT is €2.1M making its interest coverage ratio 18.6. It has cash and short-term investments of €2.8M.
Key information
47.5%
Debt to equity ratio
€8.13m
Debt
Interest coverage ratio | 18.6x |
Cash | €2.81m |
Equity | €17.12m |
Total liabilities | €15.52m |
Total assets | €32.64m |
Recent financial health updates
We Think genOway Société anonyme (EPA:ALGEN) Can Stay On Top Of Its Debt
Sep 27We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
May 31We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
Nov 01Recent updates
genOway Société anonyme's (EPA:ALGEN) Price Is Right But Growth Is Lacking
Jan 20We Think genOway Société anonyme (EPA:ALGEN) Can Stay On Top Of Its Debt
Sep 27We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
May 31We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
Nov 01Financial Position Analysis
Short Term Liabilities: ALGEN's short term assets (€20.0M) exceed its short term liabilities (€8.7M).
Long Term Liabilities: ALGEN's short term assets (€20.0M) exceed its long term liabilities (€6.8M).
Debt to Equity History and Analysis
Debt Level: ALGEN's net debt to equity ratio (31.1%) is considered satisfactory.
Reducing Debt: ALGEN's debt to equity ratio has reduced from 59.1% to 47.5% over the past 5 years.
Debt Coverage: Insufficient data to determine if ALGEN's debt is well covered by operating cash flow.
Interest Coverage: ALGEN's interest payments on its debt are well covered by EBIT (18.6x coverage).